A better characterization of the HIV reservoir is pivotal for the development of effective eradication strategies. Accurate quantification of the latent reservoir remains challenging. Starting from a regular blood draw, the Tat/Rev induced limiting dilution assay (TILDA) combines serial dilution of CD4+ T cells with a PCR-based detection of HIV-1 spliced mRNA produced upon cell stimulation. Here we adapted the original protocol for HIV-1 subtype B to detect tat/rev mRNAs transcribed from reactivated latently infected cells in long term suppressed patients infected with HIV-1 subtype C. Given the heterogeneity of global HIV epidemiology, it is pivotal to develop assays with optimal performances also in patients infected with non-B subtypes. We observed that, in these patients infected with subtype C virus, the HIV reservoir quantified by TILDA correlates with both the time of virological suppression and CD4/CD8 ratio.

, , ,
doi.org/10.1016/j.jviromet.2019.113778, hdl.handle.net/1765/121773
Journal of Virological Methods
Department of Internal Medicine

Bertoldi, A., D'Urbano, V. (Vanessa), Bon, I., Verbon, A., Rokx, C., Boucher, C. (Charles), van Kampen, J., Gruters, R., Gallinella, G. (Giorgio), Calza, L. (Leonardo), Mahmoudi, T., De Crignis, E.& Re, M.C. (Maria Carla). (2020). Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1. Journal of Virological Methods, 276.https://doi.org/10.1016/j.jviromet.2019.113778